CAREDX, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.98 USD | +1.01% |
|
+47.15% | +24.83% |
| May. 13 | Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating | MT |
| May. 10 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the CareDx, Inc. Sec...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Companyâs product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
14.98
USD
Average target price
14.4
USD
Spread / Average Target
-3.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.83% | 772M | |
| -24.86% | 9.87B | |
| -11.28% | 2.74B | |
| -12.92% | 2.24B | |
| -18.21% | 1.63B | |
| +60.76% | 1.39B | |
| -4.59% | 760M | |
| -22.45% | 516M | |
| -0.60% | 310M | |
| +6.47% | 219M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- Transcript : CareDx, Inc, Q2 2021 Earnings Call, Jul 29, 2021
